CD8 + T cells and risk for bacterial pneumonia and all-cause mortality among HIV-infected women

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 2, 2012, Pages 191-198

  Gohil, Shruti K ^a   Heo, Moonseong ^b   Schoenbaum, Ellie E ^b   Celentano, David ^c   Pirofski, Liise Anne ^b  

^a Division of Infectious Diseases   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

CD8 + T cell; HIV; Mortality; Pneumonia

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALL CAUSE MORTALITY; ARTICLE; BACTERIAL PNEUMONIA; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; DISEASE MARKER; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME; VIRUS LOAD;

ADOLESCENT; ADULT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOCYTE COUNT; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84862134733     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31824d90fe     Document Type: Article

References (41)

1. Feikin DR, Feldman C, Schuchat A, et al. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis. 2004; 4:445-455. (Pubitemid 38844129)
2. Redd SC, Rutherford GW 3rd, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990;162:1012-1017. (Pubitemid 20353577)
3. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med. 1995; 333:845-851.
4. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107: 4781-4789. (Pubitemid 43882629)
5. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A. 2007;104:6776-6781. (Pubitemid 47175577)
6. Tian H, Groner A, Boes M, et al. Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice. Infect Immun. 2007;75:1643-1650. (Pubitemid 46559428)
7. Weber SE, Tian H, Pirofski LA. CD8+ cells enhance resistance to pulmonary serotype 3 streptococcus pneumoniae infection in mice. J Immunol. 2011;186:432-442.
8. Jones HP, Tabor L, Sun X, et al. Depletion of CD8+ T cells exacerbates CD4+ Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J Immunol. 2002;168:3493-3501. (Pubitemid 34250416)
9. McAllister F, Steele C, Zheng M, et al. T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice. J Immunol. 2004;172:1132-1138. (Pubitemid 38113773)
10. Swain SD, Meissner NN, Harmsen AG. CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice. Am J Pathol. 2006;168:466-475. (Pubitemid 43271145)
11. Maeno T, Houghton AM, Quintero PA, et al. CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol. 2007;178:8090-8096. (Pubitemid 46898081)
12. van Stipdonk MJ, Hardenberg G, Bijker MS, et al. Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol. 2003;4:361-365. (Pubitemid 36432319)
13. Tzortzaki EG, Siafakas NM. A hypothesis for the initiation of COPD. Eur Respir J. 2009;34:310-315.
14. Floris-Moore M, Lo Y, Klein RS, et al. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;34:331-337. (Pubitemid 37377369)
15. Feldman C, Glatthaar M, Morar R, et al. Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults. Chest. 1999;116:107-114. (Pubitemid 29340269)
16. Kohli R, Lo Y, Homel P, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis. 2006;43:90-98. (Pubitemid 43939081)
17. Melnick SL, Sherer R, Louis TA, et al. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA. 1994; 272:1915-1921.
18. Smith DK, Warren DL, Vlahov D, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol. 1997;146: 459-469. (Pubitemid 27391406)
19. Rompalo AM, Astemborski J, Schoenbaum E, et al. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:448-454. (Pubitemid 29198283)
20. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin Immunol Immunopathol. 1989;52:10-18. (Pubitemid 19162811)
21. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881-1888. (Pubitemid 37070273)
22. Singh YG, Dar L, Singh NG. Levels of CD4 and CD8 among the inhabitants of Manipur, India. J Commun Dis. 2000;32:201-206.
23. Roederer M, Dubs JG, Anderson MT, et al. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95: 2061-2066.
24. Altfeld M, Kalife ET, Qi Y, et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med. 2006;3:e403.
25. Xing Z, Wang J, Croitoru K, et al. Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guerin infection. Infect Immun. 1998;66:5537-5542. (Pubitemid 29044656)
26. Huffnagle GB, Lipscomb MF, Lovchik JA, et al. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol. 1994;55:35-42. (Pubitemid 24039583)
27. Kolls JK, Habetz S, Shean MK, et al. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J Immunol. 1999;162:2890-2894. (Pubitemid 29309316)
28. Coleman JR, Papamichail D, Yano M, et al. Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in codonpair bias. J Infect Dis. 2011;203:1264-1273.
29. Moore TA, Perry ML, Getsoian AG, et al. Divergent role of gamma interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infection. Infect Immun. 2002;70:6310-6318. (Pubitemid 35192723)
30. Casadevall A, Pirofski LA. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol. 2003;1:17-24.
31. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(3 pt 1):822-826.
32. O'Shaughnessy TC, Ansari TW, Barnes NC, et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155: 852-857. (Pubitemid 27133393)
33. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000;132:369-372. (Pubitemid 30127775)
34. Wright TW, Gigliotti F, Finkelstein JN, et al. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest. 1999;104: 1307-1317. (Pubitemid 29536301)
35. Barry SM, Lipman MC, Deery AR, et al. Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med. 2002;3:207-211.
36. Norris KA, Morris A, Patil S, et al. Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol Res. 2006;36:175-187. (Pubitemid 46398594)
37. Bekele Y, Mengistu Y, de Wit TR, et al. Timing of blood sampling for CD4 T-cell counting influences HAART decisions. Ethiop Med J. 2011; 49:187-197.
38. Hunt PW, Cao HL, Muzoora C, et al. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS. 2011;25:2123-2131.
39. Wissinger E. Altered immune responses following influenza infection and their impact on susceptibility to bacterial pathogens. Presented at: Infectious Disease Society of America; October 22, 2010.
40. Moore M. Post-influenza secondary bacterial infections. Paper presented at: Infectious Disease Society of America; October 22, 2010; Vancouver, British Columbia, Canada.
41. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One. 2009;4:e8540.